Business
Press Release Jun 16 2023
Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled "NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine (generic for Lonsurf��) for the US market".
About this update from Natco Pharma Limited
[{"type":"text","content":" Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled \"NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine (generic for Lonsurf��) for the US market\". View Attachment","length":367,"tagName":"div"}]